Skip to main content
. 2015 Jul 26;33(51):7370–7374. doi: 10.1016/j.vaccine.2015.07.043

Table 3.

Cross-protective effects in 3-week-old SPF chickens immunized with K40/09 parent, K40/09 HP40 and K40/09 HP50 against challenge with three distinct subgroups of nephropathogenic IBV strain.

IBV strain immunizeda Genogroup of challenge virus IBV strain of challenge virusb No. of challenge virus isolated/no.of challengedc
Trachea Kidney
Control Vaccinated Control Vaccinated
K40/09 (Parent) Korean II subgroup 1 KM91 10/10 0/10*** 10/10 2/10***
Korean II subgroup 2 (QX-like) K1277/03 10/10 0/10*** 10/10 1/10***
Korean new cluster 1 K40/09 10/10 0/10*** 10/10 0/10***
K40/09 HP40 Korean II subgroup 1 KM91 10/10 0/10*** 9/10 0/10***
Korean II subgroup 2 (QX-like) K1277/03 10/10 0/10*** 10/10 0/10***
Korean new cluster 1 K40/09 10/10 0/10*** 10/10 1/10***
K40/09 HP50 Korean II subgroup 1 KM91 10/10 0/10*** 9/10 0/10***
Korean II subgroup 2 (QX-like) K1277/03 10/10 1/10*** 10/10 0/10***
Korean new cluster 1 K40/09 10/10 0/10*** 10/10 0/10***
a

Three-week-old chickens were immunized with IBV K40/09 parent, K40/09 HP40 or K40/09 HP50 (103.0 EID50/bird) via the intraocular route.

b

At 3 weeks post-immunization, all birds were challenged with 104.5 EID50 of three challenge strains via the intraocular route.

c

Five days after challenge, protection was evaluated by the absence of challenge virus in the trachea and kidney.

***

p < 0.001, by Fisher's exact test, compared to non-vaccinated control group.